首页 > 最新文献

Asia-Pacific Journal of Oncology Nursing最新文献

英文 中文
Intimate partner violence in women with cancer: An integrative review 癌症妇女中的亲密伴侣暴力:综合评论
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-11 DOI: 10.1016/j.apjon.2024.100557
Feixia Ni , Tingting Zhou , Lili Wang , Tingting Cai

Objective

This study aims to estimate the incidence of intimate partner violence (IPV) among women cancer survivors and identify associated factors.

Methods

Using Whittemore and Knafl's integrative review method, we synthesized literature on the association between IPV and cancer in women.

Results

We conducted a comprehensive search of literature published between 2003 and 2024 across eight databases, resulting in 24 English-language articles. These articles included qualitative, quantitative, and mixed-method studies. Our synthesis identified several factors influencing the relationship between IPV and cancer, including sociodemographic factors (e.g., age and income), health-related factors, lifestyle-related factors (such as life experiences and interpersonal relationships), cancer-related factors (including type and treatment), and cancer screening behaviors.

Conclusions

The study highlights that various factors contribute to the prevalence of IPV among women with cancer. Particularly vulnerable are younger patients, those with lower incomes, and those with more severe disease manifestations. Healthcare professionals should assess for IPV risk during medical consultations and ensure access to appropriate support services.

目标本研究旨在估算女性癌症幸存者中亲密伴侣暴力(IPV)的发生率,并确定相关因素。方法采用 Whittemore 和 Knafl 的综合综述方法,我们对女性 IPV 与癌症之间关系的文献进行了综合分析。结果我们通过 8 个数据库对 2003 年至 2024 年间发表的文献进行了全面检索,共检索到 24 篇英文文章。这些文章包括定性、定量和混合方法研究。我们的综述确定了影响 IPV 与癌症之间关系的几个因素,包括社会人口因素(如年龄和收入)、健康相关因素、生活方式相关因素(如生活经历和人际关系)、癌症相关因素(包括类型和治疗)以及癌症筛查行为。年轻患者、收入较低的患者以及疾病表现较严重的患者尤其容易受到影响。医护人员应在就诊时评估 IPV 风险,并确保患者能获得适当的支持服务。
{"title":"Intimate partner violence in women with cancer: An integrative review","authors":"Feixia Ni ,&nbsp;Tingting Zhou ,&nbsp;Lili Wang ,&nbsp;Tingting Cai","doi":"10.1016/j.apjon.2024.100557","DOIUrl":"10.1016/j.apjon.2024.100557","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to estimate the incidence of intimate partner violence (IPV) among women cancer survivors and identify associated factors.</p></div><div><h3>Methods</h3><p>Using Whittemore and Knafl's integrative review method, we synthesized literature on the association between IPV and cancer in women.</p></div><div><h3>Results</h3><p>We conducted a comprehensive search of literature published between 2003 and 2024 across eight databases, resulting in 24 English-language articles. These articles included qualitative, quantitative, and mixed-method studies. Our synthesis identified several factors influencing the relationship between IPV and cancer, including sociodemographic factors (e.g., age and income), health-related factors, lifestyle-related factors (such as life experiences and interpersonal relationships), cancer-related factors (including type and treatment), and cancer screening behaviors.</p></div><div><h3>Conclusions</h3><p>The study highlights that various factors contribute to the prevalence of IPV among women with cancer. Particularly vulnerable are younger patients, those with lower incomes, and those with more severe disease manifestations. Healthcare professionals should assess for IPV risk during medical consultations and ensure access to appropriate support services.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 9","pages":"Article 100557"},"PeriodicalIF":2.4,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001793/pdfft?md5=9e68abd714e9d4395802517181d437cf&pid=1-s2.0-S2347562524001793-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141711921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remembering Judi - The neighborly grandmother who spread hope 缅怀朱迪--传播希望的邻居奶奶
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-08 DOI: 10.1016/j.apjon.2024.100555
Jingmin Hu
{"title":"Remembering Judi - The neighborly grandmother who spread hope","authors":"Jingmin Hu","doi":"10.1016/j.apjon.2024.100555","DOIUrl":"10.1016/j.apjon.2024.100555","url":null,"abstract":"","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 10","pages":"Article 100555"},"PeriodicalIF":2.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S234756252400177X/pdfft?md5=20eb3157795c1d8a958e7b68af28d4a9&pid=1-s2.0-S234756252400177X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141696358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of topical corticosteroids on the prevention of acute radiation dermatitis in patients with breast cancer: An updated systematic review and meta-analysis 局部皮质类固醇对预防乳腺癌患者急性放射性皮炎的效果:最新系统综述和荟萃分析
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-06 DOI: 10.1016/j.apjon.2024.100553
Weichao Liu , Liping Wang , Dijuan Meng , Chengang Hong , Qianyu Zhang , Jinghan Yang

Objectives

To evaluate the effect of topical corticosteroids (TCS) in preventing acute radiation dermatitis in patients with breast cancer.

Methods

An updated systematic review and meta-analysis were conducted following the preferred reporting items for systematic reviews and meta-analyses. Randomized controlled trials (RCTs) in six English databases (PubMed, Web of Science, Scopus, CINAHL, Cochrane Library, Embase), three Chinese databases (Sinomed, China National Knowledge Infrastructure, Cqvip), and two clinical trial registration platforms (CHICTR, Clinicaltrials.gov) were systematically searched from inception to 1 February 2024.

Results

Thirteen RCTs were included, with 1172 patients in this updated review. Meta-analysis showed that TCS reduced the rate of moist desquamation (OR = 0.31; 95% CI = [0.22, 0.44]; P < 0.01), the incidence of Radiation Therapy Oncology Group ratings of grade 2 or higher (OR = 0.22; 95% CI = [0.14, 0.32]; P < 0.01), the incidence of Common Terminology Criteria for Adverse Events ratings of grade 2 or higher (OR = 0.56; 95% CI = [0.37, 0.84]; P < 0.01), the mean score of radiation dermatitis (SMD = −0.46; 95% CI = [−0.59, −0.34]; P < 0.01), skin erythema and hyperpigmentation readings, and improved subjective symptoms.

Conclusions

TCS can effectively prevent acute radiation dermatitis in patients with breast cancer.

Systematic review registration

Prospero (CRD42024507890).

方法按照系统综述和荟萃分析的首选报告项目进行了最新的系统综述和荟萃分析。系统检索了六个英文数据库(PubMed、Web of Science、Scopus、CINAHL、Cochrane Library、Embase)、三个中文数据库(Sinomed、China National Knowledge Infrastructure、Cqvip)和两个临床试验注册平台(CHICTR、Clinicaltrials.gov)中从开始到 2024 年 2 月 1 日的随机对照试验(RCT)。Meta分析显示,TCS降低了湿性脱屑率(OR = 0.31;95% CI = [0.22,0.44];P <;0.01)、肿瘤放疗组 2 级或更高评级的发生率(OR = 0.22;95% CI = [0.14,0.32];P <;0.01)、不良事件通用术语标准 2 级或更高评级的发生率(OR = 0.56;95% CI = [0.37,0.84];P <;0.01)。37,0.84];P <;0.01)、放射性皮炎平均得分(SMD = -0.46;95% CI = [-0.59,-0.34];P <;0.01)、皮肤红斑和色素沉着读数以及主观症状的改善。
{"title":"Effectiveness of topical corticosteroids on the prevention of acute radiation dermatitis in patients with breast cancer: An updated systematic review and meta-analysis","authors":"Weichao Liu ,&nbsp;Liping Wang ,&nbsp;Dijuan Meng ,&nbsp;Chengang Hong ,&nbsp;Qianyu Zhang ,&nbsp;Jinghan Yang","doi":"10.1016/j.apjon.2024.100553","DOIUrl":"10.1016/j.apjon.2024.100553","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the effect of topical corticosteroids (TCS) in preventing acute radiation dermatitis in patients with breast cancer.</p></div><div><h3>Methods</h3><p>An updated systematic review and meta-analysis were conducted following the preferred reporting items for systematic reviews and meta-analyses. Randomized controlled trials (RCTs) in six English databases (PubMed, Web of Science, Scopus, CINAHL, Cochrane Library, Embase), three Chinese databases (Sinomed, China National Knowledge Infrastructure, Cqvip), and two clinical trial registration platforms (CHICTR, <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span>) were systematically searched from inception to 1 February 2024.</p></div><div><h3>Results</h3><p>Thirteen RCTs were included, with 1172 patients in this updated review. Meta-analysis showed that TCS reduced the rate of moist desquamation (OR = 0.31; 95% CI = [0.22, 0.44]; <em>P</em> &lt; 0.01), the incidence of Radiation Therapy Oncology Group ratings of grade 2 or higher (OR = 0.22; 95% CI = [0.14, 0.32]; <em>P</em> &lt; 0.01), the incidence of Common Terminology Criteria for Adverse Events ratings of grade 2 or higher (OR = 0.56; 95% CI = [0.37, 0.84]; <em>P</em> &lt; 0.01), the mean score of radiation dermatitis (SMD = −0.46; 95% CI = [−0.59, −0.34]; <em>P</em> &lt; 0.01), skin erythema and hyperpigmentation readings, and improved subjective symptoms.</p></div><div><h3>Conclusions</h3><p>TCS can effectively prevent acute radiation dermatitis in patients with breast cancer.</p></div><div><h3>Systematic review registration</h3><p>Prospero (CRD42024507890).</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 9","pages":"Article 100553"},"PeriodicalIF":2.4,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001756/pdfft?md5=6ad9c4e7c70cbf74622274d3b57cb3ee&pid=1-s2.0-S2347562524001756-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141695996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of age on financial toxicity in cancer patients 年龄对癌症患者经济毒性的影响
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-05 DOI: 10.1016/j.apjon.2024.100552
Lingling Wang , Ruiqi Sun , Lidan Tian , Richard Huan Xu

Objective

The aim of this study was to assess the level of financial toxicity (FT) experienced by the following three age groups of cancer patients in China: young working-aged patients (age < 40 years), middle-aged patients (40–64 years), and older patients (≥ 65 years).

Methods

The data used for this study were collected via a cross-sectional survey conducted in China. FT was assessed using the Comprehensive Score for Financial Toxicity (COST). ANOVA was used to examine the differences in FT status between age groups. Multivariate linear regression models were employed to assess the association between age and FT, adjusted by socioeconomic and other clinical characteristics.

Results

A total of 556 cancer patients completed the survey. Approximately 54.3% of the participants were male and 45.7% were female. The majority (61.5%) were aged 40–64 years, while 27.7% were aged 65 or older. The mean FT scores for young patients (< 40 years), middle-aged patients (40–64 years), and older patients (≥ 65 years) were 16.7, 12.8, and 12.4, respectively. The results of the regression analysis revealed that, without adjusting for background characteristics, young patients had significantly higher mean COST scores. This suggests they experienced lower levels of FT compared to patients in other age groups. Stratified analysis revealed that, for older patients, only educational level and type of insurance scheme were significant factors in predicting the COST score.

Conclusions

This study provides empirical evidence for developing targeted interventions and policies to reduce the FT for patients in different age groups. Given that FT is complicated, a longitudinal study should be conducted to explore the long-term impact of FT on cancer patients' quality of life and well-being.

本研究旨在评估中国以下三个年龄组癌症患者所经历的经济毒性(FT)水平:青年工龄患者(40 岁以下)、中年患者(40-64 岁)和老年患者(≥ 65 岁)。财务毒性采用财务毒性综合评分法(COST)进行评估。方差分析用于检验不同年龄组间财务状况的差异。采用多变量线性回归模型评估年龄与财务毒性之间的关系,并根据社会经济特征和其他临床特征进行调整。约 54.3% 的参与者为男性,45.7% 为女性。大多数人(61.5%)的年龄在 40-64 岁之间,27.7%的人年龄在 65 岁或以上。年轻患者(< 40 岁)、中年患者(40-64 岁)和老年患者(≥ 65 岁)的平均 FT 分数分别为 16.7、12.8 和 12.4。回归分析结果显示,在不调整背景特征的情况下,年轻患者的平均 COST 分数明显更高。这表明,与其他年龄组的患者相比,他们的 FT 水平较低。分层分析显示,对于老年患者而言,只有教育水平和保险计划类型是预测 COST 分数的重要因素。鉴于FT的复杂性,应开展纵向研究,探讨FT对癌症患者生活质量和幸福感的长期影响。
{"title":"Influence of age on financial toxicity in cancer patients","authors":"Lingling Wang ,&nbsp;Ruiqi Sun ,&nbsp;Lidan Tian ,&nbsp;Richard Huan Xu","doi":"10.1016/j.apjon.2024.100552","DOIUrl":"10.1016/j.apjon.2024.100552","url":null,"abstract":"<div><h3>Objective</h3><p>The aim of this study was to assess the level of financial toxicity (FT) experienced by the following three age groups of cancer patients in China: young working-aged patients (age &lt; 40 years), middle-aged patients (40–64 years), and older patients (≥ 65 years).</p></div><div><h3>Methods</h3><p>The data used for this study were collected via a cross-sectional survey conducted in China. FT was assessed using the Comprehensive Score for Financial Toxicity (COST). ANOVA was used to examine the differences in FT status between age groups. Multivariate linear regression models were employed to assess the association between age and FT, adjusted by socioeconomic and other clinical characteristics.</p></div><div><h3>Results</h3><p>A total of 556 cancer patients completed the survey. Approximately 54.3% of the participants were male and 45.7% were female. The majority (61.5%) were aged 40–64 years, while 27.7% were aged 65 or older. The mean FT scores for young patients (&lt; 40 years), middle-aged patients (40–64 years), and older patients (≥ 65 years) were 16.7, 12.8, and 12.4, respectively. The results of the regression analysis revealed that, without adjusting for background characteristics, young patients had significantly higher mean COST scores. This suggests they experienced lower levels of FT compared to patients in other age groups. Stratified analysis revealed that, for older patients, only educational level and type of insurance scheme were significant factors in predicting the COST score.</p></div><div><h3>Conclusions</h3><p>This study provides empirical evidence for developing targeted interventions and policies to reduce the FT for patients in different age groups. Given that FT is complicated, a longitudinal study should be conducted to explore the long-term impact of FT on cancer patients' quality of life and well-being.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 9","pages":"Article 100552"},"PeriodicalIF":2.4,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001744/pdfft?md5=3959b32187c19fad61d30a1ba59f8e04&pid=1-s2.0-S2347562524001744-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141693973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy 与免疫检查点抑制剂疗法相关的免疫相关不良事件的最新管理方法和新趋势
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-04 DOI: 10.1016/j.apjon.2024.100549
Ninh M. La-Beck, Jesuwapelumi Owoso

The rapidly expanding class of therapies targeting immune checkpoints for the treatment of various cancers now includes 8 clinically approved agents: a lymphocyte-activation gene 3 (LAG-3) inhibitor (relatlimab), a cytotoxic T lymphocyte associated protein 4 (CTLA-4) inhibitor (ipilimumab), three programmed cell death protein 1 (PD-1) inhibitors (nivolumab, pembrolizumab and cemiplimab), and three programmed cell death ligand-1 (PD-L1) inhibitors (atezolizumab, durvalumab, and avelumab). Previously, we reviewed the mechanisms of immune-related adverse events (irAEs), strategies for management of irAEs, and highlighted similarities as well as differences amongst clinical guidelines from the National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Society for Immunotherapy of Cancer (SITC), and European Society for Medical Oncology (ESMO). Herein, we provide an update that includes discussion of changes to these clinical guidelines since our last review, the new LAG-3 targeted agents, emerging patterns of irAEs, and new directions for improved monitoring and treatment of irAEs that could incorporate interdisciplinary pharmacist-led teams, artificial intelligence, and pharmacogenomics.

以免疫检查点为靶点治疗各种癌症的疗法种类迅速增加,目前已获得临床批准的药物有 8 种:一种淋巴细胞活化基因 3 (LAG-3) 抑制剂(relatlimab)、一种细胞毒性 T 淋巴细胞相关蛋白 4 (CTLA-4) 抑制剂(ipilimumab)、三种程序性细胞死亡蛋白 1 (PD-1) 抑制剂(nivolumab、pembrolizumab 和 cemiplimab)以及三种程序性细胞死亡配体 1 (PD-L1) 抑制剂(atezolizumab、durvalumab 和 avelumab)。在此之前,我们回顾了免疫相关不良事件(irAEs)的发生机制、irAEs 的处理策略,并强调了美国国立综合癌症网络(NCCN)、美国临床肿瘤学会(ASCO)、美国癌症免疫治疗学会(SITC)和欧洲肿瘤内科学会(ESMO)的临床指南之间的相似之处和不同之处。在此,我们将提供最新进展,包括讨论自上次回顾以来这些临床指南的变化、新的 LAG-3 靶向药物、新出现的 irAEs 模式,以及改进 irAEs 监测和治疗的新方向(可纳入跨学科药剂师领导的团队、人工智能和药物基因组学)。
{"title":"Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy","authors":"Ninh M. La-Beck,&nbsp;Jesuwapelumi Owoso","doi":"10.1016/j.apjon.2024.100549","DOIUrl":"10.1016/j.apjon.2024.100549","url":null,"abstract":"<div><p>The rapidly expanding class of therapies targeting immune checkpoints for the treatment of various cancers now includes 8 clinically approved agents: a lymphocyte-activation gene 3 (LAG-3) inhibitor (relatlimab), a cytotoxic T lymphocyte associated protein 4 (CTLA-4) inhibitor (ipilimumab), three programmed cell death protein 1 (PD-1) inhibitors (nivolumab, pembrolizumab and cemiplimab), and three programmed cell death ligand-1 (PD-L1) inhibitors (atezolizumab, durvalumab, and avelumab). Previously, we reviewed the mechanisms of immune-related adverse events (irAEs), strategies for management of irAEs, and highlighted similarities as well as differences amongst clinical guidelines from the National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Society for Immunotherapy of Cancer (SITC), and European Society for Medical Oncology (ESMO). Herein, we provide an update that includes discussion of changes to these clinical guidelines since our last review, the new LAG-3 targeted agents, emerging patterns of irAEs, and new directions for improved monitoring and treatment of irAEs that could incorporate interdisciplinary pharmacist-led teams, artificial intelligence, and pharmacogenomics.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 9","pages":"Article 100549"},"PeriodicalIF":2.4,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001719/pdfft?md5=7ff6f74b9a4165f178464fc976e4a9bf&pid=1-s2.0-S2347562524001719-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141690142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remembering Judi 缅怀朱迪
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100550
Kazuko Onishi
{"title":"Remembering Judi","authors":"Kazuko Onishi","doi":"10.1016/j.apjon.2024.100550","DOIUrl":"10.1016/j.apjon.2024.100550","url":null,"abstract":"","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 9","pages":"Article 100550"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001720/pdfft?md5=12a2ebf822bc160e2e4b4a017fded768&pid=1-s2.0-S2347562524001720-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141708857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of socioeconomic inequality on access to health care for patients with advanced cancer: A qualitative study 社会经济不平等对晚期癌症患者获得医疗服务的影响:定性研究
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100520
Anna Santos Salas , Bronwen LeGuerrier , Lucas Horvath , Nahyeni Bassah , Bisi Adewale , Olga Bardales , Wendy Duggleby , Bukola Salami , Sharon M. Watanabe

Objective

In Canada, populations experiencing socioeconomic inequality have lower rates of access to screening and diagnosis and higher mortality rates than people from higher-income areas. Limited evidence exists concerning their experiences when living with advanced cancer. We explored how socioeconomic inequality shapes the experiences of patients with advanced cancer.

Methods

We utilized a qualitative study design that combined tenets of hermeneutic phenomenological inquiry and critical theory. Four individuals with advanced cancer from low-income neighborhoods, three family members, and six cancer care providers were accrued through a tertiary cancer center in a western Canadian city. One-on-one interviews and brief notes were used for data collection. Data were analyzed through thematic analysis.

Results

Three interrelated themes were identified: ‘Lack of access to socioeconomic supports,’ ‘Gaps in access to health care resources and services,’ and ‘Limited access to symptom relief.’ Patients experienced inadequate finances, housing, and transportation. Most patients lived alone and had limited family and social support. Patients reported lack of knowledge of available resources and health system navigation issues, including communication problems with providers and among levels of care. Cancer care providers and patients described issues achieving symptom relief as well as challenges associated with extensive disease.

Conclusions

Study findings suggest that socioeconomic inequality interferes with the ability of persons with advanced cancer to access health care and contributes to less optimal cancer outcomes. Socioeconomic inequality may increase symptom severity. Findings call for the development of tailored interventions for populations with advanced cancer and socioeconomic inequality.

目标在加拿大,与来自高收入地区的人相比,社会经济不平等人口的筛查和诊断率较低,死亡率较高。有关他们晚期癌症生活经历的证据有限。我们探讨了社会经济不平等如何影响晚期癌症患者的经历。方法我们采用了定性研究设计,结合了诠释学现象学探究和批判理论的原则。我们通过加拿大西部城市的一家三级癌症中心收集了四名来自低收入社区的晚期癌症患者、三名家庭成员和六名癌症护理人员。采用一对一访谈和简要记录的方式收集数据。结果确定了三个相互关联的主题:结果确定了三个相互关联的主题:"缺乏社会经济支持"、"获得医疗资源和服务方面的差距 "和 "缓解症状的途径有限"。患者在经济、住房和交通方面都存在不足。大多数患者独居,家庭和社会支持有限。患者报告称,他们缺乏对可用资源和医疗系统导航问题的了解,包括与医疗服务提供者和各级医疗机构之间的沟通问题。研究结果表明,社会经济不平等影响了晚期癌症患者获得医疗服务的能力,并导致癌症治疗效果不理想。社会经济不平等可能会加重症状的严重程度。研究结果呼吁为晚期癌症患者和社会经济不平等人群制定有针对性的干预措施。
{"title":"The impact of socioeconomic inequality on access to health care for patients with advanced cancer: A qualitative study","authors":"Anna Santos Salas ,&nbsp;Bronwen LeGuerrier ,&nbsp;Lucas Horvath ,&nbsp;Nahyeni Bassah ,&nbsp;Bisi Adewale ,&nbsp;Olga Bardales ,&nbsp;Wendy Duggleby ,&nbsp;Bukola Salami ,&nbsp;Sharon M. Watanabe","doi":"10.1016/j.apjon.2024.100520","DOIUrl":"10.1016/j.apjon.2024.100520","url":null,"abstract":"<div><h3>Objective</h3><p>In Canada, populations experiencing socioeconomic inequality have lower rates of access to screening and diagnosis and higher mortality rates than people from higher-income areas. Limited evidence exists concerning their experiences when living with advanced cancer. We explored how socioeconomic inequality shapes the experiences of patients with advanced cancer.</p></div><div><h3>Methods</h3><p>We utilized a qualitative study design that combined tenets of hermeneutic phenomenological inquiry and critical theory. Four individuals with advanced cancer from low-income neighborhoods, three family members, and six cancer care providers were accrued through a tertiary cancer center in a western Canadian city. One-on-one interviews and brief notes were used for data collection. Data were analyzed through thematic analysis.</p></div><div><h3>Results</h3><p>Three interrelated themes were identified: ‘Lack of access to socioeconomic supports,’ ‘Gaps in access to health care resources and services,’ and ‘Limited access to symptom relief.’ Patients experienced inadequate finances, housing, and transportation. Most patients lived alone and had limited family and social support. Patients reported lack of knowledge of available resources and health system navigation issues, including communication problems with providers and among levels of care. Cancer care providers and patients described issues achieving symptom relief as well as challenges associated with extensive disease.</p></div><div><h3>Conclusions</h3><p>Study findings suggest that socioeconomic inequality interferes with the ability of persons with advanced cancer to access health care and contributes to less optimal cancer outcomes. Socioeconomic inequality may increase symptom severity. Findings call for the development of tailored interventions for populations with advanced cancer and socioeconomic inequality.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100520"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001422/pdfft?md5=3614a6a250776eeb7e2ce9cbc3fcf43c&pid=1-s2.0-S2347562524001422-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information needs preferences of Chinese colorectal cancer patients receiving chemotherapy: A discrete choice experiment 中国结直肠癌化疗患者的信息需求偏好:离散选择实验
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100551
Linlin Li, Xueli Liu, Wanjun Zhou, Yawen Zhang, Xinqiong Zhang

Objective

The study aims to investigate the information needs and preferences of colorectal cancer (CRC) patients undergoing chemotherapy using a discrete choice experiment (DCE) to optimize and improve the information support strategy for these patients.

Methods

Between May and July 2023, 165 patients with CRC who were receiving chemotherapy at a single hospital in China completed the questionnaire. The survey instruments included a general information questionnaire, a DCE questionnaire, and the Brief Health Literacy Screening Scale. A conditional logit model was used with Stata 16.0 software to analyze patients' preferences.

Results

A total of 159 valid questionnaires were collected, and the questionnaire response rate was 96.4%. All 7 included attributes had an impact on patients' information needs preference (P < 0.05). Among them, information providers, knowledge content, and social support had high relative importance, which were 12.16%, 7.57% and 2.25%, respectively. Patients showed a preference for attending doctors (β = 1.9439, P < 0.05) and primary nurses (β = 1.7985, P < 0.05). Providing knowledge related to disease basis, treatment, and health promotion also had a significant impact (β = 1.6224, P < 0.05).

Conclusions

Healthcare professionals should be the primary information source for patients and improve the accessibility of information by establishing professional information platforms or identifying reliable channels. It is recommended to provide continuous information on treatment and health promotion to CRC patients at various stages of chemotherapy. Attention should be paid to identifying and providing measures to alleviate the economic and psychological burden and to meet the social support needs of patients.

方法2023年5月至7月,165名在中国某医院接受化疗的结直肠癌(CRC)患者填写了调查问卷。调查工具包括一般信息问卷、DCE问卷和简明健康素养筛查量表。结果 共收集到 159 份有效问卷,问卷回收率为 96.4%。所有 7 个属性都对患者的信息需求偏好有影响(P < 0.05)。其中,信息提供者、知识内容和社会支持的相对重要性较高,分别为 12.16%、7.57% 和 2.25%。患者偏好主治医生(β = 1.9439,P < 0.05)和初级护士(β = 1.7985,P < 0.05)。结论医护人员应成为患者的主要信息来源,并通过建立专业信息平台或确定可靠渠道来提高信息的可及性。建议在化疗的不同阶段为 CRC 患者提供持续的治疗和健康促进信息。应注意确定和提供减轻患者经济和心理负担的措施,满足患者的社会支持需求。
{"title":"Information needs preferences of Chinese colorectal cancer patients receiving chemotherapy: A discrete choice experiment","authors":"Linlin Li,&nbsp;Xueli Liu,&nbsp;Wanjun Zhou,&nbsp;Yawen Zhang,&nbsp;Xinqiong Zhang","doi":"10.1016/j.apjon.2024.100551","DOIUrl":"10.1016/j.apjon.2024.100551","url":null,"abstract":"<div><h3>Objective</h3><p>The study aims to investigate the information needs and preferences of colorectal cancer (CRC) patients undergoing chemotherapy using a discrete choice experiment (DCE) to optimize and improve the information support strategy for these patients.</p></div><div><h3>Methods</h3><p>Between May and July 2023, 165 patients with CRC who were receiving chemotherapy at a single hospital in China completed the questionnaire. The survey instruments included a general information questionnaire, a DCE questionnaire, and the Brief Health Literacy Screening Scale. A conditional logit model was used with Stata 16.0 software to analyze patients' preferences.</p></div><div><h3>Results</h3><p>A total of 159 valid questionnaires were collected, and the questionnaire response rate was 96.4%. All 7 included attributes had an impact on patients' information needs preference (<em>P</em> &lt; 0.05). Among them, information providers, knowledge content, and social support had high relative importance, which were 12.16%, 7.57% and 2.25%, respectively. Patients showed a preference for attending doctors (β = 1.9439, <em>P</em> &lt; 0.05) and primary nurses (β = 1.7985, <em>P</em> &lt; 0.05). Providing knowledge related to disease basis, treatment, and health promotion also had a significant impact (β = 1.6224, <em>P</em> &lt; 0.05).</p></div><div><h3>Conclusions</h3><p>Healthcare professionals should be the primary information source for patients and improve the accessibility of information by establishing professional information platforms or identifying reliable channels. It is recommended to provide continuous information on treatment and health promotion to CRC patients at various stages of chemotherapy. Attention should be paid to identifying and providing measures to alleviate the economic and psychological burden and to meet the social support needs of patients.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 9","pages":"Article 100551"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001732/pdfft?md5=ede280030163ba7d8bcf7e23e4e2f8c8&pid=1-s2.0-S2347562524001732-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141701588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In their voices: Kenyan women's experiences with cancer treatment–related side effects 她们的心声:肯尼亚妇女在癌症治疗副作用方面的经历
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100502
Tayreez Mushani , Dinah Kassaman , Sharon Brownie , Peterson Kiraithe , Margaret Barton-Burke

Objective

This article reports on a secondary analysis of a qualitative study conducted in Nairobi, Kenya that reported several initial themes. In this article, the authors explore the theme of treatment-related side effect management by women receiving treatment for breast or cervical cancer.

Methods

Women were interviewed at three points during their active treatment trajectory. Participants were purposefully selected and saturation was reached when interviews did not yield any new themes. The interviews were transcribed and analyzed for internal consistency, frequency, extensiveness, intensity and specificity. The Nvivo pro 12 software was used in organizing and managing the data to facilitate analysis.

Results

Eighteen women were interviewed. Major side effects reported by participants included fatigue, alopecia, skin and nail changes as well as nausea and vomiting. Women who received information prior to treatment were more comfortable managing side effects. Participants described the impact of side effects on their daily life, body image, and many sought comfort through faith. Some women provided suggestions on strategies for patient education.

Conclusions

This study attempted to capture the cancer treatment-related experiences of Kenyan women in their own voices and present strategies for future intervention and research. The care of individuals receiving treatment can be enhanced through the advancement of health human resources, the development of nationally accessible patient education materials and research on regionally relevant strategies to manage cancer treatment-related side effects.

本文报告了对在肯尼亚内罗毕进行的一项定性研究的二次分析,该研究报告了几个初步的主题。在本文中,作者探讨了接受乳腺癌或宫颈癌治疗的妇女对治疗相关副作用的管理这一主题。对参与者进行了有目的的选择,当访谈没有产生任何新的主题时,访谈达到饱和。对访谈内容进行转录,并对其内部一致性、频率、广泛性、强度和特异性进行分析。在组织和管理数据时使用了 Nvivo pro 12 软件,以方便分析。参与者报告的主要副作用包括疲劳、脱发、皮肤和指甲变化以及恶心和呕吐。在治疗前获得相关信息的妇女在处理副作用时更加得心应手。参与者描述了副作用对其日常生活和身体形象的影响,许多人通过信仰寻求安慰。本研究试图以肯尼亚妇女的口吻记录她们与癌症治疗相关的经历,并为未来的干预和研究提供策略。可以通过提高卫生人力资源、编写全国通用的患者教育材料以及研究与地区相关的控制癌症治疗相关副作用的策略来加强对接受治疗者的护理。
{"title":"In their voices: Kenyan women's experiences with cancer treatment–related side effects","authors":"Tayreez Mushani ,&nbsp;Dinah Kassaman ,&nbsp;Sharon Brownie ,&nbsp;Peterson Kiraithe ,&nbsp;Margaret Barton-Burke","doi":"10.1016/j.apjon.2024.100502","DOIUrl":"10.1016/j.apjon.2024.100502","url":null,"abstract":"<div><h3>Objective</h3><p>This article reports on a secondary analysis of a qualitative study conducted in Nairobi, Kenya that reported several initial themes. In this article, the authors explore the theme of treatment-related side effect management by women receiving treatment for breast or cervical cancer.</p></div><div><h3>Methods</h3><p>Women were interviewed at three points during their active treatment trajectory. Participants were purposefully selected and saturation was reached when interviews did not yield any new themes. The interviews were transcribed and analyzed for internal consistency, frequency, extensiveness, intensity and specificity. The Nvivo pro 12 software was used in organizing and managing the data to facilitate analysis.</p></div><div><h3>Results</h3><p>Eighteen women were interviewed. Major side effects reported by participants included fatigue, alopecia, skin and nail changes as well as nausea and vomiting. Women who received information prior to treatment were more comfortable managing side effects. Participants described the impact of side effects on their daily life, body image, and many sought comfort through faith. Some women provided suggestions on strategies for patient education.</p></div><div><h3>Conclusions</h3><p>This study attempted to capture the cancer treatment-related experiences of Kenyan women in their own voices and present strategies for future intervention and research. The care of individuals receiving treatment can be enhanced through the advancement of health human resources, the development of nationally accessible patient education materials and research on regionally relevant strategies to manage cancer treatment-related side effects.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100502"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001240/pdfft?md5=8269f3ca6414300bba61346005c50f01&pid=1-s2.0-S2347562524001240-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-disclosure, perceived social support, and reproductive concerns among young male cancer patients in China: A mediating model analysis 中国年轻男性癌症患者的自我披露、感知到的社会支持和生殖问题:中介模型分析
IF 2.4 3区 医学 Q1 NURSING Pub Date : 2024-07-01 DOI: 10.1016/j.apjon.2024.100503
Lihua Wu , Xingyu Chen , Tingting Dong , Wei Yan , Linying Wang , Wanling Li

Objective

Many young male cancer patients experience reproductive concerns. Self-disclosure might be able to improve patients’ perceived social support and reproductive concerns. Nevertheless, these relationships have not yet been confirmed among young male cancer patients. This study aims to investigate the level of reproductive concerns and to identify the mediating role of perceived social support between self-disclosure and reproductive concerns among young male cancer patients in China by developing a structural model.

Methods

This study was a quantitative, cross-sectional design. We used the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement guidelines to report this study. A total of 369 young male cancer survivors were recruited by convenience sampling from two tertiary hospitals in Taiyuan, Shanxi, China. Data were collected using a “general data questionnaire”, “distress disclosure index” (DDI), “perceived social support scale” (PSSS), and “reproductive concerns after cancer-male” (RCAC-M) via the WeChat mini program “Questionnaire Star” and paper questionnaire. Descriptive statistics, Pearson correlation analyses, and structural equation models were adopted to analyze the data.

Results

Reproductive concerns were at moderate levels and negatively associated with self-disclosure (r = −0.619, P < 0.01) and perceived social support (r = −0.599, P < 0.01). Self-disclosure indirectly influenced reproductive concerns (−0.328∼–0.159, P < 0.001) through perceived social support.

Conclusions

Self-disclosure and perceived social support are closely associated with reproductive concerns in young male cancer patients, and perceived social support is a mediator between self-disclosure and reproductive concerns. Healthcare providers could reduce reproductive concerns by enhancing self-disclosure and improving perceived social support.

Trial registration

This study was registered on ClinicalTrials.gov on June 13, 2023 (NCT05914181).

目的 许多年轻男性癌症患者都有生殖方面的顾虑。自我披露可能会改善患者感知到的社会支持和生殖问题。然而,这些关系尚未在年轻男性癌症患者中得到证实。本研究旨在通过建立一个结构模型,调查中国年轻男性癌症患者的生殖顾虑水平,并确定感知到的社会支持在自我披露和生殖顾虑之间的中介作用。我们采用加强流行病学观察性研究报告(STROBE)声明指南来报告本研究。我们从山西太原的两家三级甲等医院以方便抽样的方式招募了369名年轻男性癌症幸存者。通过微信小程序 "问卷星 "和纸质问卷收集了 "一般数据问卷"、"痛苦揭示指数"(DDI)、"感知社会支持量表"(PSSS)和 "癌症后生殖问题-男性"(RCAC-M)。结果生殖顾虑与自我披露(r = -0.619,P < 0.01)和感知社会支持(r = -0.599,P < 0.01)呈中度负相关。结论自我披露和感知到的社会支持与年轻男性癌症患者的生殖顾虑密切相关,感知到的社会支持是自我披露和生殖顾虑之间的中介。医疗服务提供者可以通过加强自我披露和改善感知的社会支持来减少生殖顾虑。试验注册本研究于 2023 年 6 月 13 日在 ClinicalTrials.gov 上注册(NCT05914181)。
{"title":"Self-disclosure, perceived social support, and reproductive concerns among young male cancer patients in China: A mediating model analysis","authors":"Lihua Wu ,&nbsp;Xingyu Chen ,&nbsp;Tingting Dong ,&nbsp;Wei Yan ,&nbsp;Linying Wang ,&nbsp;Wanling Li","doi":"10.1016/j.apjon.2024.100503","DOIUrl":"10.1016/j.apjon.2024.100503","url":null,"abstract":"<div><h3>Objective</h3><p>Many young male cancer patients experience reproductive concerns. Self-disclosure might be able to improve patients’ perceived social support and reproductive concerns. Nevertheless, these relationships have not yet been confirmed among young male cancer patients. This study aims to investigate the level of reproductive concerns and to identify the mediating role of perceived social support between self-disclosure and reproductive concerns among young male cancer patients in China by developing a structural model.</p></div><div><h3>Methods</h3><p>This study was a quantitative, cross-sectional design. We used the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement guidelines to report this study. A total of 369 young male cancer survivors were recruited by convenience sampling from two tertiary hospitals in Taiyuan, Shanxi, China. Data were collected using a “general data questionnaire”, “distress disclosure index” (DDI), “perceived social support scale” (PSSS), and “reproductive concerns after cancer-male” (RCAC-M) via the WeChat mini program “Questionnaire Star” and paper questionnaire. Descriptive statistics, Pearson correlation analyses, and structural equation models were adopted to analyze the data.</p></div><div><h3>Results</h3><p>Reproductive concerns were at moderate levels and negatively associated with self-disclosure (<em>r</em> = −0.619, <em>P</em> &lt; 0.01) and perceived social support (<em>r</em> = −0.599, <em>P</em> &lt; 0.01). Self-disclosure indirectly influenced reproductive concerns (−0.328∼–0.159, <em>P</em> &lt; 0.001) through perceived social support.</p></div><div><h3>Conclusions</h3><p>Self-disclosure and perceived social support are closely associated with reproductive concerns in young male cancer patients, and perceived social support is a mediator between self-disclosure and reproductive concerns. Healthcare providers could reduce reproductive concerns by enhancing self-disclosure and improving perceived social support.</p></div><div><h3>Trial registration</h3><p>This study was registered on <span>ClinicalTrials.gov</span><svg><path></path></svg> on June 13, 2023 (NCT05914181).</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":"11 7","pages":"Article 100503"},"PeriodicalIF":2.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001252/pdfft?md5=bdc91e3280d1f7f356a9ae6e2e36bc0a&pid=1-s2.0-S2347562524001252-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141029445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asia-Pacific Journal of Oncology Nursing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1